Statistics for Accelerate Diagnostics (id:5722 AXDX)

Valuation metrics

Market cap

42.57M

Enterprise value

79.31M

Trailing P/E (ttm)

-0.34

Forward P/E

-0.99

PEG ratio

-0.99

Price/Sales (ttm)

3.48

Price/Book (mrq)

-0.87

Enterprise Value/Revenue

6.48

Enterprise Value/EBITDA

-1.94

Overview

Shares outstanding

25.04M

Float

12.26M

Shares short

473.08K

% Held by insiders

0.41%

% Held by institutions

0.17%

Average volume (10 days)

48.31K

Average volume (90 days)

Price summary

52-Week low

0.73

52-Week high

5.23

52-Week change

-172.94%

Beta

0.60

50-Day moving average

1.78

200-Day moving average

1.34

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

July 12th, 2023

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

21.15%

Operating margin

-288.21%

Operational effectiveness

Return on assets

-75.85%

Return on equity

309.82%

Income statement

Revenue (ttm)

0.66

Revenue per share (ttm)

0.66

Quarterly revenue growth (yoy)

Gross profit (ttm)

2.55M

EBITDA

-40,770,000.00

Net income to common (ttm)

-37,906,000.00

Diluted EPS (ttm)

-2.59

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

9.75M

Total cash per share (mrq)

0.41

Total debt (mrq)

42.41M

Total Debt/Equity (mrq)

-0.87

Current ratio (mrq)

128.00%

Book value per share (mrq)

-1.36

Cash flow

Cash flow statement

-32,043,000.00

Levered free cash flow (LFCF)

-54,674,248.00